1-4 of 4
Tomas Janik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from the Cohort-Expansion Stage of a Phase I Trial of Tinostamustine Monotherapy in Advanced Hodgkin Lymphoma (HL), Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM) (NCT02576496)

Anna Maria Sureda Balari, Herve Ghesquieres, Franck Morschhauser, Pim Mutsaers, Enrique M Ocio, Tomas Janik, Nick Manamley, Kasia Hilgier, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 1706.
https://doi.org/10.1182/blood-2023-181822
Published: 2023
Journal Articles

Results from the Cohort Expansion Stage of a Phase I Trial of Tinostamustine Monotherapy in Advanced Haematological Malignancies (NCT02576496): Findings from a Subset of Patients with Cutaneous T-Cell Lymphoma (CTCL)

Pier Luigi Zinzani, Franck Morschhauser, Tomas Janik, Nick Manamley, Kasia Hilgier, Anna Maria Sureda Balari
Journal: Blood
Blood (2023) 142 (Supplement 1): 4432.
https://doi.org/10.1182/blood-2023-180878
Published: 2023
Journal Articles

Safety and Efficacy of Tinostamustine in Pre-Treated Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL): Early Results from an Additional Expansion Cohort of a Phase I Study

Anna Sureda, Antonio Pinto, Herve Ghesquieres, Franck Morschhauser, Olivier Tournilhac, Pim Mutseaers, Josée M. Zijlstra, Floris A. De Jong, Tomas Janik, Pier Luigi Zinzani
Journal: Blood
Blood (2022) 140 (Supplement 1): 3696–3697.
https://doi.org/10.1182/blood-2022-162231
Published: 2022
Journal Articles

Safety and Efficacy of Tinostamustine in Heavily Pre-Treated Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)

Herve Ghesquieres, Antonio Pinto, Anna Sureda, Olivier Tournilhac, Franck Morschhauser, Tomas Janik, Pier Luigi Zinzani
Journal: Blood
Blood (2021) 138 (Supplement 1): 2472.
https://doi.org/10.1182/blood-2021-148483
Published: 2021